rachel60+FollowNew NHS Cancer Treatment Gives Fresh HopeBig news for women fighting advanced womb cancer: the NHS just approved a new treatment called pembrolizumab (aka Keytruda) that’s proven to slow cancer growth and boost survival rates. It’s an immunotherapy given with chemo, and trials show it cuts the risk of death by 26% compared to chemo alone. About 2,100 women a year in England could benefit. This is a major step forward for better outcomes and more time with loved ones! #Health #BodyHealth #CancerTreatment467Share
Michael Austin+FollowCancer Drug Approval Sends Stock BuzzingHeads up, stock-watchers: UroGen just got the green light from the FDA for its new bladder cancer treatment, and the stock popped 9% right after. Instead of surgery, patients can now get a weekly treatment—way less hassle. Wall Street’s suddenly super optimistic, with some calling for the stock to nearly triple. The big twist? The FDA said yes even after a panel said no, showing they’ll bend the rules for much-needed meds. Retail investors are hyped, and chatter’s heating up! #StockMarket #FDAApproval #CancerTreatment #Business #Market31815Share
Jacqueline Howard DDS+FollowSound Waves vs. Cancer? NHS Says Yes!Get this: the NHS is about to start zapping liver tumors with SOUND WAVES. No surgery, no chemo, just a 30-minute ultrasound session that literally pops cancer cells with “bubble clouds.” It’s called histotripsy and it’s already shown solid results in the US. First UK patients get it this summer in Cambridge, and if it works, it could be a total game-changer for other cancers too. Imagine beating cancer and being home the same day! #CancerTreatment #NHS #MedicalInnovation #Health #BodyHealth30Share
rachel60+FollowCancer Conference Hype: Real Wins for Patients?Every year, the ASCO cancer conference drops major headlines about new treatments, but do they actually help patients? Turns out, yes! Drugs like Enhertu, Verzenio, and Trodelvy are now FDA-approved and making a real difference—think longer survival, fewer side effects, and better quality of life for breast and lung cancer patients. Plus, new gene-targeted meds are doubling the time some cancers stay in check. The hype is real: these breakthroughs are changing lives! #CancerResearch #ASCO #CancerTreatment #Health80Share
Michelle Welch+FollowALL Survival Rates Just Got a BoostBig news for anyone following leukemia treatments: patients with relapsed or refractory ALL who got blinatumomab (BLI) and inotuzumab ozogamicin (INO) before stem cell transplants had way better survival rates than those who got standard chemo. The BLI/INO group saw more than double the 2-year survival compared to chemo! Remission rates were also much higher. There’s a catch—more risk of liver complications—so docs need to keep an eye out. Still, this could be a real game-changer for ALL patients! #LeukemiaResearch #ALL #CancerTreatment #MedicalBreakthrough #StemCellTransplant #Health320Share
Denise Lester+FollowAustria’s First CyberKnife Treatments!Big news for cancer care in Austria: patients at the CyberKnife Center Salzburg are now getting treated with the super-precise CyberKnife System! This tech means fewer hospital visits—just 1 to 5 sessions instead of 30-40. It’s all about ultra-targeted radiation, so people can get top-notch treatment without spending weeks away from home. Game changer for anyone who can’t travel for long treatments! #CyberKnife #CancerTreatment #MedicalInnovation #Austria #HealthTech #Health00Share
rachel60+FollowCancer Treatment Just Got a Major UpgradeA new cancer jab is about to make life way easier for patients in England—one shot, 15 minutes, and it treats 15 different types of cancer! No more hour-long IV drips. The NHS is rolling out this game-changing vaccine (nivolumab) next month, and it’s expected to save thousands of hours for both patients and doctors. Plus, England’s the first in Europe to offer it. Seriously, this could be a huge step forward for cancer care! #CancerTreatment #NHS #MedicalInnovation #HealthNews #GameChanger #Health34814Share
